Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.
Kade BirkelandRaj M KhandwallaIlan KedanChrisandra L ShufeltPuja K MehtaMargo B MinissianJanet WeiEileen M HandbergLouise Ej ThomsonDaniel S BermanJohn W PetersenR David AndersonGalen Cook-WiensCarl J PepineC Noel Bairey MerzPublished in: JMIR research protocols (2017)
Clinicaltrials.gov NCT01342029; https://clinicaltrials.gov/ct2/show/NCT01342029 (Archived by WebCite at http://www.webcitation.org/6uyd6B2PO).
Keyphrases
- coronary artery disease
- computed tomography
- coronary artery
- study protocol
- clinical trial
- oxidative stress
- open label
- phase iii
- randomized controlled trial
- contrast enhanced
- image quality
- magnetic resonance imaging
- phase ii
- dual energy
- heart failure
- positron emission tomography
- magnetic resonance
- combination therapy
- smoking cessation